In this study, we demonstrated that SNS is efficacious and safe in treating MMD among breast cancer patients, improving quality of life and TCM syndrome scores, with the Lactobacillus-Indole-CD8+ T axis playing a potential role in the pharmacological activity of SNS. The gene discussed is CD8A; the disease is breast carcinoma.